587 related articles for article (PubMed ID: 28640695)
41. Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide.
Ramalho J; Semelka RC; AlObaidy M; Ramalho M; Nunes RH; Castillo M
Eur Radiol; 2016 Nov; 26(11):4080-4088. PubMed ID: 26911888
[TBL] [Abstract][Full Text] [Related]
42. Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents.
Jost G; Lenhard DC; Sieber MA; Lohrke J; Frenzel T; Pietsch H
Invest Radiol; 2016 Feb; 51(2):83-9. PubMed ID: 26606548
[TBL] [Abstract][Full Text] [Related]
43. Dentate nucleus signal intensity changes on T1-weighted MRI after repeated administrations of linear and macrocyclic gadolinium-based contrast agents: a pediatric intraindividual case-control study.
Ozturk K; Nascene D
Acta Radiol; 2022 Jul; 63(7):914-922. PubMed ID: 34018821
[TBL] [Abstract][Full Text] [Related]
44. Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosis.
Eisele P; Szabo K; Ebert A; Radbruch A; Platten M; Schoenberg SO; Gass A
Magn Reson Imaging; 2019 May; 58():1-5. PubMed ID: 30630068
[TBL] [Abstract][Full Text] [Related]
45. Gadoxetate disodium, a modern hepatospecific MRI contrast agent: Indirect signs for gadolinium deposition in the brain structures with signal intensity increase after intravenous application.
Holesta M; Weichet J; Wagnerova MG; Lukavsky J; Malikova H
Neurol India; 2018; 66(6):1771-1775. PubMed ID: 30504579
[TBL] [Abstract][Full Text] [Related]
46. Contrast Agent-Induced High Signal Intensity in Dentate Nucleus on Unenhanced T1-Weighted Images: Comparison of Gadodiamide and Gadoxetic Acid.
Ichikawa S; Motosugi U; Omiya Y; Onishi H
Invest Radiol; 2017 Jul; 52(7):389-395. PubMed ID: 28195932
[TBL] [Abstract][Full Text] [Related]
47. Global and Regional Brain Assessment with Quantitative MR Imaging in Patients with Prior Exposure to Linear Gadolinium-based Contrast Agents.
Kuno H; Jara H; Buch K; Qureshi MM; Chapman MN; Sakai O
Radiology; 2017 Apr; 283(1):195-204. PubMed ID: 27797676
[TBL] [Abstract][Full Text] [Related]
48. Gadolinium deposition in the paediatric brain: T1-weighted hyperintensity within the dentate nucleus following repeated gadolinium-based contrast agent administration.
Young JR; Orosz I; Franke MA; Kim HJ; Woodworth D; Ellingson BM; Salamon N; Pope WB
Clin Radiol; 2018 Mar; 73(3):290-295. PubMed ID: 29208312
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of Gadolinium Deposition in the Brain After MR Arthrography.
Kralik SF; Singhal KK; Frank MS; Ladd LM
AJR Am J Roentgenol; 2018 Nov; 211(5):1063-1067. PubMed ID: 30106613
[TBL] [Abstract][Full Text] [Related]
50. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
[TBL] [Abstract][Full Text] [Related]
51. Higher magnetic susceptibility of globus pallidus in patients after macrocyclic GBCAs: assessment using quantitative susceptibility mapping.
Zhang J; Xie L; Yang X; Xu L; Chen K; Luo Y; Yu C
Acta Radiol; 2023 Jul; 64(7):2261-2267. PubMed ID: 36567675
[TBL] [Abstract][Full Text] [Related]
52. Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.
Stojanov DA; Aracki-Trenkic A; Vojinovic S; Benedeto-Stojanov D; Ljubisavljevic S
Eur Radiol; 2016 Mar; 26(3):807-15. PubMed ID: 26105022
[TBL] [Abstract][Full Text] [Related]
53. Comparison of Gadolinium Concentrations within Multiple Rat Organs after Intravenous Administration of Linear versus Macrocyclic Gadolinium Chelates.
McDonald RJ; McDonald JS; Dai D; Schroeder D; Jentoft ME; Murray DL; Kadirvel R; Eckel LJ; Kallmes DF
Radiology; 2017 Nov; 285(2):536-545. PubMed ID: 28640692
[TBL] [Abstract][Full Text] [Related]
54. High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted MR Images: Comparison between Gadobutrol and Linear Gadolinium-Based Contrast Agents.
Moser FG; Watterson CT; Weiss S; Austin M; Mirocha J; Prasad R; Wang J
AJNR Am J Neuroradiol; 2018 Mar; 39(3):421-426. PubMed ID: 29419400
[TBL] [Abstract][Full Text] [Related]
55. Quantitative assessment of gadolinium deposition in dentate nucleus using quantitative susceptibility mapping.
Hinoda T; Fushimi Y; Okada T; Arakawa Y; Liu C; Yamamoto A; Okada T; Yoshida K; Miyamoto S; Togashi K
J Magn Reson Imaging; 2017 May; 45(5):1352-1358. PubMed ID: 27664936
[TBL] [Abstract][Full Text] [Related]
56. Changes in signal intensity in the dentate nucleus at unenhanced T1-weighted magnetic resonance imaging depending on class of previously used gadolinium-based contrast agent.
Kasper E; Schemuth HP; Horry S; Kinner S
Pediatr Radiol; 2018 May; 48(5):686-693. PubMed ID: 29417165
[TBL] [Abstract][Full Text] [Related]
57. Impact of Kidney Function on CNS Gadolinium Deposition in Patients Receiving Repeated Doses of Gadobutrol.
Dogra S; Borja MJ; Lui YW
AJNR Am J Neuroradiol; 2021 May; 42(5):824-830. PubMed ID: 33632738
[TBL] [Abstract][Full Text] [Related]
58. The switch from Gd-DTPA to Gd-DOTA is not associated with decrease of the T1 signal intensity of the pallidus and dentate in a pediatric population.
Gulino P; Bianchi A; Diciotti S; Scionti A; Sali L; Papadopulos P; Mascalchi M
Acta Radiol; 2021 Mar; 62(3):368-376. PubMed ID: 32529894
[TBL] [Abstract][Full Text] [Related]
59. Signal intensity increases in dentate nucleus/globus pallidus/pulvinar on unenhanced T1WI MR images after multiple examinations with gadodiamide.
Koiso T; Yamamoto M; Watanabe S; Barfod BE
Neuroradiol J; 2019 Jun; 32(3):215-224. PubMed ID: 30924388
[TBL] [Abstract][Full Text] [Related]
60. T1 signal intensity in the dentate nucleus after the administration of the macrocyclic gadolinium-based contrast agent gadoterate meglumine: An observational study.
Ramalho J; Semelka RC; Cruz J; Morais T; Ramalho M
Radiologia (Engl Ed); 2022; 64(5):397-406. PubMed ID: 36243439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
